Clinical Trial Update: Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating immunotherapy with Y90 radioembolization for metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: University of Iowa | Conditions: Colorectal Cancer Metastatic, Colon Cancer | Phase 1 | Status: TERMINATED